SARCOGNATO, SAMANTHA
 Distribuzione geografica
Continente #
NA - Nord America 1.690
AS - Asia 968
EU - Europa 747
AF - Africa 277
SA - Sud America 227
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 3.932
Nazione #
US - Stati Uniti d'America 1.554
SG - Singapore 392
IT - Italia 216
CN - Cina 169
BR - Brasile 141
HK - Hong Kong 95
DE - Germania 91
VN - Vietnam 50
FI - Finlandia 41
NL - Olanda 38
PL - Polonia 35
SE - Svezia 33
CI - Costa d'Avorio 29
GB - Regno Unito 28
FR - Francia 27
PK - Pakistan 27
RU - Federazione Russa 23
MX - Messico 19
TR - Turchia 17
AL - Albania 16
CA - Canada 16
AR - Argentina 14
ES - Italia 14
SA - Arabia Saudita 14
AT - Austria 13
EG - Egitto 13
IN - India 13
JP - Giappone 13
AO - Angola 12
BG - Bulgaria 12
BJ - Benin 12
CO - Colombia 12
JM - Giamaica 12
JO - Giordania 12
ZA - Sudafrica 12
KR - Corea 11
ML - Mali 11
UA - Ucraina 11
BA - Bosnia-Erzegovina 10
BB - Barbados 10
CZ - Repubblica Ceca 10
EC - Ecuador 10
HU - Ungheria 10
MU - Mauritius 10
PE - Perù 10
TJ - Tagikistan 10
AE - Emirati Arabi Uniti 9
CV - Capo Verde 9
KE - Kenya 9
RE - Reunion 9
AM - Armenia 8
BD - Bangladesh 8
BO - Bolivia 8
BW - Botswana 8
ET - Etiopia 8
GM - Gambi 8
MY - Malesia 8
MZ - Mozambico 8
NP - Nepal 8
RS - Serbia 8
SI - Slovenia 8
UY - Uruguay 8
VE - Venezuela 8
BY - Bielorussia 7
BZ - Belize 7
CG - Congo 7
CW - ???statistics.table.value.countryCode.CW??? 7
EE - Estonia 7
GN - Guinea 7
GT - Guatemala 7
ID - Indonesia 7
IQ - Iraq 7
IR - Iran 7
MD - Moldavia 7
MN - Mongolia 7
PA - Panama 7
TZ - Tanzania 7
CL - Cile 6
CM - Camerun 6
CU - Cuba 6
CY - Cipro 6
DK - Danimarca 6
GF - Guiana Francese 6
HR - Croazia 6
IE - Irlanda 6
KZ - Kazakistan 6
LB - Libano 6
LV - Lettonia 6
LY - Libia 6
MW - Malawi 6
NA - Namibia 6
NO - Norvegia 6
RW - Ruanda 6
TH - Thailandia 6
TN - Tunisia 6
ZW - Zimbabwe 6
AD - Andorra 5
AF - Afghanistan, Repubblica islamica di 5
AU - Australia 5
BE - Belgio 5
Totale 3.720
Città #
Ashburn 239
Singapore 213
Fairfield 178
Chandler 157
Woodbridge 98
Hong Kong 94
Houston 91
Cambridge 76
Beijing 63
Padova 60
Santa Clara 48
Wilmington 45
Seattle 44
Los Angeles 41
Boardman 32
Abidjan 28
San Diego 26
Munich 25
Ann Arbor 24
Medford 23
Princeton 23
Ho Chi Minh City 22
Bytom 21
Helsinki 21
São Paulo 20
New York 17
Chicago 14
Nuremberg 14
Rome 14
Milan 13
Turku 13
Cotonou 12
Des Moines 12
Hanoi 12
Amman 11
Buffalo 11
Luanda 11
Tirana 11
Bridgetown 10
Kingston 10
Warsaw 10
Brooklyn 9
Florence 9
Johannesburg 9
Mestre 9
Montreal 9
Orem 9
Stockholm 9
Vienna 9
Addis Ababa 8
Bamako 8
Dushanbe 8
Frankfurt am Main 8
Conakry 7
Dar es Salaam 7
Lahore 7
London 7
Minsk 7
Montevideo 7
Nairobi 7
Nanjing 7
Panama City 7
Praia 7
Quito 7
Roxbury 7
Sahiwal 7
Tokyo 7
Willemstad 7
Yerevan 7
Cairo 6
Chisinau 6
Denver 6
Dhaka 6
Kigali 6
Lima 6
Ljubljana 6
Maputo 6
Mexico City 6
Riyadh 6
Shenyang 6
Tallinn 6
Ulan Bator 6
Amsterdam 5
Andorra la Vella 5
Atlanta 5
Belize City 5
Guatemala City 5
Harare 5
Havana 5
Jinan 5
Lappeenranta 5
Lilongwe 5
Lusaka 5
Managua 5
Podgorica 5
Riga 5
San Jose 5
Sofia 5
The Dalles 5
Veneto 5
Totale 2.291
Nome #
Changes in microRNA expression during disease progression in patients with chronic viral hepatitis 255
The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver 236
Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma 225
The diagnostic value of cytology in parotid Warthin's tumors: international multicenter series 180
Perianal tailgut cyst 178
Obliterative portal venopathy without portal hypertension: An underestimated condition 175
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 169
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis 168
Benign biliary neoplasms and biliary tumor precursors 151
Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis 148
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis 147
Pathology of idiopathic non cirrhotic portal hypertension. 141
The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD 135
Expression of adrenomedullin in chronic inflammatory liver diseases 129
Pathology of autoimmune hepatitis 129
Necroptosis in Cholangiocarcinoma 128
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH 127
Pathology of non-alcoholic fatty liver disease 121
Prognostic meaning of BAP1 and PBRM1 expression in intrahepatic cholangiocarcinoma 120
Cholangiocarcinoma 118
Metastasis to parotid gland from non Head and Neck tumors 117
Hepatocellular carcinoma: a clinical and pathological overview 114
The Neglected Role of Bile Duct Epithelial Cells in NASH 111
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 109
Ferroptosis in Intrahepatic Cholangiocarcinoma: IDH1105GGT Single Nucleotide Polymorphism Is Associated With Its Activation and Better Prognosis 98
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic 90
Benign biliary neoplasms and biliary tumor precursors 86
Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma 78
Totale 3.983
Categoria #
all - tutte 14.734
article - articoli 14.423
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 0 0 0 0 3 10 19 23 9 24 22
2021/2022387 29 54 27 19 25 42 25 16 44 7 32 67
2022/2023304 55 37 18 35 41 37 14 11 32 3 18 3
2023/2024208 12 30 24 18 21 30 20 6 0 6 11 30
2024/2025880 9 57 44 34 83 29 44 80 87 57 130 226
2025/20261.658 198 225 396 519 317 3 0 0 0 0 0 0
Totale 3.983